Antibacterial drug therapy. Focus on new drugs.
This article will focus on the drugs for which there has been a recent or renewed interest in veterinary medicine. Some of these are new drugs that were recently introduced. Others discussed may be human-label drugs for which there has been recent interest in veterinary medicine because of the need for a more active drug or convenient regimen. For drugs such as the aminoglycosides included here, recent information has provided us with updated dosage guidelines.
Papich
M G
MG
Department of Anatomy, Physiological Sciences, and Radiology, College of Veterinary Medicine, North Carolina State University, Raleigh, USA. mark__papich@ncsu.edu
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000145:classification / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000662:veterinary*; D015780:Carbapenems / Q000145:classification / Q000627:therapeutic use; D002511:Cephalosporins / Q000145:classification / Q000627:therapeutic use; D024841:Fluoroquinolones; D006020:Glycopeptides; D018942:Macrolides; D010406:Penicillins / Q000145:classification / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D015780:Carbapenems; D002511:Cephalosporins; D024841:Fluoroquinolones; D006020:Glycopeptides; D018942:Macrolides; D010406:Penicillins